Transplant vs no transplant: the IFM 2009 clinical trial in multiple myeloma
T-cell lymphoma: autologous or allogeneic transplant?
Relapsed follicular lymphoma: hope from a non-chemotherapy regimen of lenalidomide and obinutuzumab
Advances in multiple myeloma treatment over the last years
The differences between biological and chronological age, with their implications on AML treatment